Healthcare -
Biotechnology - NASDAQ - US
$ 2.15
-9.66 %
$ 18.5 M
Market Cap
-0.84
P/E
LSTA - COST OF REVENUE
Cost of Revenue LSTA - Lisata Therapeutics, Inc.
189 K
LAST VALUE
85.37%
2 YEAR CAGR
-3.43%
5 YEAR CAGR
-34.47%
10 YEAR CAGR